Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 21, 2023; 29(23): 3606-3621
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3606
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3606
Figure 3 Effects of BMI-1 overexpressed hepatic stellate cell conditioned medium on cell proliferation and migration of colorectal cancer cells.
A: Viability of HCT116 and DLD-1 cells cultured in conditioned medium (CM) from negative control (NC) LX2 (NC CM) or CM from BMI-1 overexpressed LX2 (BMI-1 CM) was confirmed by the Cell Counting Kit-8 assay; B: Colony formation assay of colorectal cancer (CRC) cells cultured in NC CM or BMI-1 CM; C: Wound healing assay of CRC cells cultured in NC CM or BMI-1 CM, the healing percentages were calculated at 24 h and 48 h; D: Transwell migration assay of CRC cells cultured in NC CM or BMI-1 CM, the numbers of cells which migrated were counted; E: Quantitative polymerase chain reaction assay of the expression of epithelial-mesenchymal transition (EMT)-related markers in CRC cells cultured in NC CM or BMI-1 CM; F: Western blot assays of the expression of EMT-related markers in CRC cells cultured in NC CM or BMI-1 CM; G: Immunofluorescence analysis showed that vimentin and Snail expression levels were increased in CRC cells cultured in BMI-1 CM. bP < 0.01, cP < 0.001 vs NC CM. DAPI: 4',6-diamidino-2-phenylindole.
- Citation: Jiang ZY, Ma XM, Luan XH, Liuyang ZY, Hong YY, Dai Y, Dong QH, Wang GY. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells. World J Gastroenterol 2023; 29(23): 3606-3621
- URL: https://www.wjgnet.com/1007-9327/full/v29/i23/3606.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i23.3606